Bryn Mawr Capital Management LLC Trims Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Bryn Mawr Capital Management LLC cut its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 11.5% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 33,843 shares of the healthcare conglomerate’s stock after selling 4,412 shares during the period. UnitedHealth Group comprises approximately 0.9% of Bryn Mawr Capital Management LLC’s portfolio, making the stock its 19th largest position. Bryn Mawr Capital Management LLC’s holdings in UnitedHealth Group were worth $17,120,000 at the end of the most recent reporting period.

Other large investors have also recently made changes to their positions in the company. National Pension Service grew its position in UnitedHealth Group by 1.6% during the 4th quarter. National Pension Service now owns 1,731,922 shares of the healthcare conglomerate’s stock worth $876,110,000 after purchasing an additional 27,362 shares during the last quarter. Fjell Capital LLC acquired a new position in UnitedHealth Group in the 4th quarter valued at about $857,000. Lingotto Investment Management LLP acquired a new stake in UnitedHealth Group during the 4th quarter worth approximately $3,597,000. FFT Wealth Management LLC increased its holdings in shares of UnitedHealth Group by 13.0% in the fourth quarter. FFT Wealth Management LLC now owns 1,456 shares of the healthcare conglomerate’s stock valued at $736,000 after purchasing an additional 168 shares during the period. Finally, Longbow Finance SA lifted its holdings in shares of UnitedHealth Group by 5.0% during the fourth quarter. Longbow Finance SA now owns 25,150 shares of the healthcare conglomerate’s stock worth $12,722,000 after purchasing an additional 1,191 shares during the period. 87.86% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In other UnitedHealth Group news, Director Timothy Patrick Flynn purchased 1,000 shares of the firm’s stock in a transaction on Friday, January 17th. The shares were purchased at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the transaction, the director now owns 4,500 shares in the company, valued at $2,302,065. This represents a 28.57 % increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 0.33% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

UNH has been the subject of several analyst reports. Deutsche Bank Aktiengesellschaft increased their price target on shares of UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a report on Tuesday, December 3rd. Stephens lifted their price objective on UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a report on Thursday, December 5th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $700.00 price target on shares of UnitedHealth Group in a research note on Friday, January 17th. Hsbc Global Res raised shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a report on Friday, January 10th. Finally, Truist Financial lowered their target price on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a report on Monday, January 6th. One equities research analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Buy” and a consensus price target of $629.32.

UnitedHealth Group Stock Performance

Shares of NYSE UNH opened at $470.49 on Wednesday. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The firm’s 50-day moving average price is $518.22 and its two-hundred day moving average price is $559.08. The stock has a market capitalization of $432.99 billion, a P/E ratio of 30.35, a P/E/G ratio of 1.37 and a beta of 0.61. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $630.73.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, beating the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm had revenue of $100.81 billion for the quarter, compared to analysts’ expectations of $101.60 billion. During the same period last year, the firm earned $5.83 EPS. The firm’s revenue was up 6.8% compared to the same quarter last year. As a group, sell-side analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th will be issued a $2.10 dividend. This represents a $8.40 annualized dividend and a dividend yield of 1.79%. The ex-dividend date is Monday, March 10th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.19%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.